Abstract:Lu Chen, 1, &ast Yu Zhong, 2, &ast Yong-Sheng Li, 3 He Zhuang, 4 Xin Li, 5 Sheng-Ping Liu, 5 Jing-Gang Li, 5 Qiu Lin, 4 Fei Gao 5 1 Department of Paediatrics, Fujian Maternity and Child Health Hospital, College of Clinical Medicine for Obstetrics and Gynecology and Pediatrics, Fujian Medical University, Fuzhou, 350000, People's Republic of China; 2 Department of Pharmaceutical Analysis, Faculty of Pharmacy, Fujian Medical University, Fuzhou, 350122, People's Republic of China; 3 Department of Urology, Fujian Medical University Union Hospital, Fuzhou, 350001, People's Republic of China; 4 Department of Clinical Laboratory, Fujian Medical University Union Hospital, Fuzhou, 350001, People's Republic of China; 5 Fujian Institute of Hematology, Fujian Provincial Key Laboratory on Hematology, Fujian Medical University Union Hospital, Fuzhou, 350001, People's Republic of China &astThese authors contributed equally to this work Correspondence: Fei Gao, Email Background: Accurate, sensitive, and rapid identification of leukemia cells in blood and bone marrow is of paramount significance for clinical diagnosis. An integrative technique combining traditional cytomorphology with immunophenotyping was proposed to improve the diagnostic efficiency in leukemia. On account of high photostability, biocompatibility, and signal-to-background ratio, upconversion nanoparticles (UCNPs) as luminescent labels have drawn substantial research scrutiny in immunolabeling. Methods: To achieve simultaneous determination, NaYF 4 :Yb,Er UCNPs were coupled with CD38 antibodies to construct immunofluorescence probes that were developed to bind to diffuse large B cell lymphoma (DLBCL) cells, followed by Wright's staining that has been widely used in clinical work for morphological diagnosis. Further, the experimental conditions were optimized, such as medium, slice-making method, antibody dosage, incubation time, etc. Results: The cell morphology and immunolabeling could be observed simultaneously, and its simple operation rendered it a possibility for clinical diagnosis. The developed immunolabeling assay could achieve DLBCL cell counting with high reproducibility and stability, and the detection limit was as low as 1.54 cell/slice (> 3 σ/s). Moreover, the proposed method also realized real blood and bone marrow sample analysis, and the results were consistent with the clinical diagnosis. Conclusion: Overall, this strategy can be carried out after simple laboratory training and has prospective biomedical applications in leukemia classification, diagnosis validation, and differential diagnostics. Graphical Keywords: leukemia, upconversion nanoparticle, immunofluorescence probe, Wright's staining, cytomorphology Graphical Leukemia, a generic term, encompasses several life threatening malignant disorders that present with incremental amounts of leucocytes in blood and bone marrow. Leukemia cells have the innate ability for migration and invasion. 1 Dedifferentiated and malignant leucocytes not only retain the benign leucocytes capacity for cell motility and survival in the circulation, but obtain the potential for rapid and uncontrolled cell division. 1 Accordingly, leukemia is aggressive and is a challenging disease to treat. Regrettably, leukemia may occur at all ages from the newborn to the aged with different forms and various age distributions. 2 Rapid and accurate diagnosis of leukemia is vital to prevent disease progression and reduce mortality. Currently, the common diagnostic techniques toward leukemia principally lean on cytomorphology, cytochemistry, immunophenotyping (flow cytometry, FCM), cytogenetics (chromosome analysis and fluorescence in situ hybridization), and molecular genetics (polymerase chain reaction and sequencing technique). 3–5 Regrettably, there is a shortage of FCM equipment, and other cytogenetics and molecular genetics methods available at laboratory diagnostic centers require expensive equipment, experienced personnel, immediate processing, tedious operation, and so on. 6,7 Correspondingly, cytomorphology is an indispensable approach in hematological disease diagnosis owing to its fast evaluation of specimens, thus endowing time-saving and cost-effective characteristics. Specifically, trained hematologists can distinguish abnormalities in cell morphology or potential leukemia cells from normal counterparts. 8 Further, assessment of the percentage and relative distribution of erythropoiesis, granulopoiesis, and monocytopoiesis can identif -Abstract Truncated-

Automatic Characterization of Leukemic Cells with 2D Light Scattering Static Cytometry

Interannual to decadal variability in climate and the glacier mass balance in Washington, Western Canada, and Alaska

Machine Learning Approaches to Automated Flow Cytometry Diagnosis of Chronic Lymphocytic Leukemia

[Role of Flow Cytometry in the Diagnosis of Chronic Myeloid Leukemia].

Discriminating Leukemia Cellular Heterogeneity and Screening Metabolite Biomarker Candidates using Label-Free Mass Cytometry

3D side-scattering imaging flow cytometer and convolutional neural network for label-free cell analysis

Dioptrics of the periphery of the eye.

Immunophenotyping of 222 Children with Acute Leukemia by Multi-Color Flow Cytometry

Imaging Flow Cytometry and Convolutional Neural Network-Based Classification Enable Discrimination of Hematopoietic and Leukemic Stem Cells in Acute Myeloid Leukemia

Identification and Staging of B-Cell Acute Lymphoblastic Leukemia Using Quantitative Phase Imaging and Machine Learning

Rapid analysis of white blood cells with diffraction imaging flow cytometry

Label-free, rapid and highly accurate identification and categorization of leukemia cells via Raman spectroscopy

A Novel and Rapid Smear Cytomorphology Detection Strategy Based on Upconversion Nanoparticles Immunolabeling Integrated with Wright's Staining for Accurate Diagnosis of Leukemia

A Segmentation Method Based on HMRF for the Aided Diagnosis of Acute Myeloid Leukemia

B-142 Development and Clinical Validation of Artificial Intelligence Assisted Flow Cytometry Diagnosis for Acuteleukemia

The State of the Art in the Development of Biosimilars

Label-free hematology analysis method based on defocusing phase-contrast imaging under illumination of 415 nm light

Acute Myeloid Leukemia: Diagnosis and Evaluation by Flow Cytometry

Label‐Free Identification of White Blood Cells Using Machine Learning

Label-free microfluidic chip for segregation and recovery of circulating leukemia cells: clinical applications in acute myeloid leukemia

Automated Deep Learning-Based Diagnosis and Molecular Characterization of Acute Myeloid Leukemia Using Flow Cytometry